list of glp-1 drugs for weight loss How medications are transforming diabetes and treatment Comparing Popular GLP-1 Medications

As we follow long-term outcomes of current therapies with new medications coming to market, it will be crucial to continue to evaluate lipid-specific outcomes that play a role in the overall cardiovascular benefits of GLP-1RA and other highly effective anti-obesity medications

GLP-1 receptors are expressed in pancreatic islet -cells, pulmonary epithelial cells, atrial cardiac myocytes, vagal afferent neurons, neurons in a number of brain regions, as well as cells lining gastric pits and small intestinal mucosa

Garza K, Aminpour E, Shah J, et al

Around a quarter (26%) of people diagnosed with heart disease have used GLP-1 medications, and 22% of people diagnosed as being overweight or obese say they have used them or are currently using them

Prices are already falling

This multi-dimensional therapeutic potential is reshaping the positioning of GLP-1 drugs as comprehensive metabolic treatments rather than just glucose-lowering agents For instance, Novo Nordisks semaglutide is now marketed as Wegovy specifically for chronic weight management, while Eli Lillys tirzepatide has received FDA approval under the brand name Zepbound for obesity treatment, independent of diabetic status